Ambrosia Investment Limited and Jolt Capital SAS acquired 42.98% stake in Alpha MOS S.A. (ENXTPA:ALM) from Diagnostic Medical Systems S.A. (ENXTPA:DGM) for €6.5 million on June 26, 2017. Under the terms of the transaction, 14.38 million shares will be acquired for €0.45 per share. Post transaction, Ambrosia and Jolt Capital will jointly hold 69% stake in Alpha MOS. Ambrosia and Jolt Capital will launch a tender offer for the acquisition of remaining stake in Alpha MOS at a price of €0.45 per share. As a result of this transaction, Jean-Paul Ansel, Chief Executive Officer of Diagnostic Medical Systems Group, resigned from the Chairmanship of the Board of Directors of Alpha MOS and from the post of Chief Executive Officer of the company. Adrien Tardy will serve as a new Director, Herve Martin will serve as Director general of Alpha MOS and Laurent Samama as the Chairman of the Board of Directors. Hélène Reltgen and Olivier Sichel will serve as independent Directors. Anne Tolila and Regis Henry of Gide acted as legal advisors to Jolt Capital SAS. Saam Golshani and Julien Bensaid of Orrick acted as legal advisors to Ambrosia Investments Limited. Philippe Touzet and Jean-Pierree Saidy acted as legal advisors to Diagnostic Medical Systems S.A.

Ambrosia Investment Limited and Jolt Capital SAS completed the acquisition of 42.98% stake in Alpha MOS S.A. (ENXTPA:ALM) from Diagnostic Medical Systems S.A. (ENXTPA:DGM) on June 26, 2017.